Long acting compositions
View Patent ↗The present invention relates to a long-acting composition for the treatment of an animal in need thereof wherein the composition includes a therapeutically effective amount of a bioactive agent, characterized in that the composition includes a non-aqueous carrier and a solvent system comprising castor oil and at least one cyclic amide.
1. A long-acting veterinary pharmaceutical composition comprising a therapeutically effective amount of a bioactive agent, a non-aqueous carrier, and a solvent system comprising castor oil and at least one cyclic amide;
wherein the bioactive agent is an anthelmintic compound; and
wherein the cyclic amide is a pyrrolidone.
2. The composition as claimed in claim 1 wherein the cyclic amide is N-Methylpyrrolidone (NMP).
3. The composition as claimed in claim 1 wherein the cyclic amide is present in an amount between 1-50% w/v.
4. The composition as claimed in claim 1 wherein the castor oil is present in an amount between 1-20% w/v.
5. The composition as claimed in claim 1 wherein the composition is an injectable composition.
6. The composition as claimed in claim 1 wherein the anthelmintic is selected from the group consisting of avermectin, moxidectin, milbemycin, ivermectin, abamectin, doramectin, eprinomectin and selamectin.
7. The composition as claimed in claim 1 wherein the anthelmintic compound is present in an amount between 0.005 to 5% w/v.
8. The composition as claimed in claim 6 wherein the anthelmintic compound is moxidectin.
9. The composition as claimed in claim 1 wherein the non-aqueous carrier comprises an oil selected from the group consisting of canola oil, corn oil, cottonseed oil, olive oil, peanut oil, sesame oil, soybean oil, safflower oil, coconut oil, sunflower oil, palm oil, monoglyceride, diglyceride and triglyceride medium chain succinic acid triglyceride.
10. The composition as claimed in claim 1 wherein the cyclic amide is present in an amount of approximately 15% w/v.
11. The composition as claimed in claim 1 wherein the castor oil is present in an amount of approximately 7% w/v.
12. The composition as claimed in claim 1 further comprising an antioxidant.
13. The composition as claimed in claim 12 wherein the antioxidant is butylated hydroxytoluene (BHT).
14. The composition as claimed in claim 12 wherein the antioxidant is present in an amount between 0.001 to 10% w/v.
15. The composition as claimed in claim 12 wherein the antioxidant is present in an amount of approximately 0.05% w/v.
16. A method of treating a parasitic infection in an animal in need thereof comprising administering to the animal a composition as claimed in claim 1 .
17. The method as claimed in claim 16 wherein the treatment of the parasitic infection persists for at least 50 days after administration of the composition.
18. A method of preparing a long-acting veterinary pharmaceutical composition according to claim 1 comprising:
a) adding the bioactive agent to the cyclic amide solvent;
b) adding castor oil to the bioactive agent/cyclic amide mixture; and
c) adding a non-aqueous carrier to the resulting mixture.